Users describe migraines, eye pain and months of fatigue, as an FDA advisory panel stacked with industry-tied doctors votes to ease limits on six unapproved peptides.
Recap by typeshit. Full story at KFF Health News.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
A short Facebook post says very few people get Ozempic for free and calls the drug effective for health. The claim is the poster's own, with no detail given.
Researchers found people on GLP-1 medications for weight loss or diabetes reported hair loss and nails lifting off more often than people who never used them.
Loading…